Literature DB >> 31953917

Orthobiologics for the Hip Region: A Narrative Review.

Kelly C McInnis1, Eric T Chen2, Jonathan T Finnoff3, Eugene Y Roh4, Joanne Borg Stein1.   

Abstract

Management of hip region disorders is challenging. Orthobiologic treatments including platelet rich plasma (PRP), mesenchymal stem cells, and amniotic injectables have gained popularity as promising treatments despite a lack of robust evidence for their effectiveness. We review rationale and current evidence for orthobiologics for three common hip region conditions: hip osteoarthritis, gluteal tendinopathy, and proximal hamstring tendinopathy. Overall, the current state of evidence is extremely limited for orthobiologic treatments and is predominantly relevant to PRP injections. There is currently a lack of data to support the use of mesenchymal stem cells or amniotic injectables in these conditions of the hip.
© 2020 American Academy of Physical Medicine and Rehabilitation.

Entities:  

Mesh:

Year:  2020        PMID: 31953917     DOI: 10.1002/pmrj.12327

Source DB:  PubMed          Journal:  PM R        ISSN: 1934-1482            Impact factor:   2.298


  2 in total

Review 1.  Orthobiologics: Current role in Orthopedic Surgery and Traumatology.

Authors:  Alonso Moreno-Garcia; E Carlos Rodriguez-Merchan
Journal:  Arch Bone Jt Surg       Date:  2022-07

2.  Comprehensive Evaluation of Primary Care Sports Medicine Fellowship Websites.

Authors:  Robert Pagan-Rosado; Mark Friedrich Hurdle; Claudia Jimenez; Andrea Cheville; Raul A Rosario-Concepcion
Journal:  J Med Educ Curric Dev       Date:  2021-07-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.